Pranav S Garimella1, Ronit Katz2, Sushrut S Waikar3, Anand Srivastava4, Insa Schmidt3, Andrew Hoofnagle5, Ragnar Palsson6, Helmut G Rennke7, Isaac E Stillman8, Ke Wang9, Bryan R Kestenbaum9, Joachim H Ix10. 1. Division of Nephrology-Hypertension, University of California San Diego, La Jolla; Kidney Health, Research and Innovation Hub of San Diego, San Diego, CA. Electronic address: pgarimella@health.ucsd.edu. 2. Departments of Obstetrics and Gynecology, University of Washington, Seattle, WA. 3. Section of Nephrology, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA. 4. Division of Nephrology and Hypertension, Center for Translational Metabolism and Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. 5. Laboratory Medicine, University of Washington, Seattle, WA. 6. Division of Nephrology, Landspitali-The National University Hospital of Iceland, Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland. 7. Department of Pathology, Brigham and Women's Hospital, Boston, MA. 8. Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA. 9. Department of Medicine, Division of Nephrology, University of Washington, Seattle, WA; Kidney Research Institute, Seattle, WA. 10. Division of Nephrology-Hypertension, University of California San Diego, La Jolla.
Abstract
RATIONALE & OBJECTIVE: Tubular secretion plays an important role in the efficient elimination of endogenous solutes and medications, and lower secretory clearance is associated with risk of kidney function decline. We evaluated whether histopathologic quantification of interstitial fibrosis and tubular atrophy (IFTA) is associated with lower tubular secretory clearance in persons undergoing kidney biopsy. STUDY DESIGN: Cross-sectional. SETTINGS & PARTICIPANTS: The Boston Kidney Biopsy Cohort is a study of persons undergoing native kidney biopsies for clinical indications. EXPOSURES: Semiquantitative score of IFTA reported by 2 trained pathologists. OUTCOMES: We measured plasma and urine concentrations of 9 endogenous secretory solutes using a targeted liquid chromatography/mass spectrometry assay. We used linear regression to test associations of urine-to-plasma ratios (UPRs) of these solutes with IFTA score after controlling for estimated glomerular filtration rate (eGFR) and albuminuria. RESULTS: Among 418 participants, mean age was 53 years, 51% were women, 64% were White, and 18% were Black. Mean eGFR was 50mL/min/1.73m2, and median urinary albumin-creatinine ratio was 819mg/g. Compared with individuals with≤25% IFTA, those with>50% IFTA had 12%-37% lower UPRs for all 9 secretory solutes. Adjusting for age, sex, race, eGFR, and urine albumin and creatinine levels attenuated the associations, yet a trend of lower secretion across groups remained statistically significant (P<0.05 for trend) for 7 of 9 solutes. A standardized composite secretory score incorporating UPR for all 9 secretory solutes using the min-max method showed similar results (P<0.05 for trend). LIMITATIONS: Single time point and spot measures of secretory solutes. CONCLUSIONS: Greater IFTA severity is associated with lower clearance of endogenous secretory solutes even after adjusting for eGFR and albuminuria.
RATIONALE & OBJECTIVE: Tubular secretion plays an important role in the efficient elimination of endogenous solutes and medications, and lower secretory clearance is associated with risk of kidney function decline. We evaluated whether histopathologic quantification of interstitial fibrosis and tubular atrophy (IFTA) is associated with lower tubular secretory clearance in persons undergoing kidney biopsy. STUDY DESIGN: Cross-sectional. SETTINGS & PARTICIPANTS: The Boston Kidney Biopsy Cohort is a study of persons undergoing native kidney biopsies for clinical indications. EXPOSURES: Semiquantitative score of IFTA reported by 2 trained pathologists. OUTCOMES: We measured plasma and urine concentrations of 9 endogenous secretory solutes using a targeted liquid chromatography/mass spectrometry assay. We used linear regression to test associations of urine-to-plasma ratios (UPRs) of these solutes with IFTA score after controlling for estimated glomerular filtration rate (eGFR) and albuminuria. RESULTS: Among 418 participants, mean age was 53 years, 51% were women, 64% were White, and 18% were Black. Mean eGFR was 50mL/min/1.73m2, and median urinary albumin-creatinine ratio was 819mg/g. Compared with individuals with≤25% IFTA, those with>50% IFTA had 12%-37% lower UPRs for all 9 secretory solutes. Adjusting for age, sex, race, eGFR, and urine albumin and creatinine levels attenuated the associations, yet a trend of lower secretion across groups remained statistically significant (P<0.05 for trend) for 7 of 9 solutes. A standardized composite secretory score incorporating UPR for all 9 secretory solutes using the min-max method showed similar results (P<0.05 for trend). LIMITATIONS: Single time point and spot measures of secretory solutes. CONCLUSIONS: Greater IFTA severity is associated with lower clearance of endogenous secretory solutes even after adjusting for eGFR and albuminuria.
Authors: Andrew D Rule; Hatem Amer; Lynn D Cornell; Sandra J Taler; Fernando G Cosio; Walter K Kremers; Stephen C Textor; Mark D Stegall Journal: Ann Intern Med Date: 2010-05-04 Impact factor: 25.391
Authors: Dennis G Moledina; Isaac E Hall; Heather Thiessen-Philbrook; Peter P Reese; Francis L Weng; Bernd Schröppel; Mona D Doshi; F Perry Wilson; Steven G Coca; Chirag R Parikh Journal: Am J Kidney Dis Date: 2017-08-24 Impact factor: 8.860
Authors: Pranav S Garimella; Kefeng Li; Jane C Naviaux; Michael G Shlipak; Joseph A Abdelmalek; Erick Castro; Edmund V Capparelli; Robert K Naviaux; Joachim H Ix Journal: Am J Kidney Dis Date: 2017-03-08 Impact factor: 8.860
Authors: Ke Wang; Michelle Nguyen; Yan Chen; Andrew N Hoofnagle; Jessica O Becker; Leila R Zelnick; John Kundzins; Anne Goodling; Jonathan Himmelfarb; Bryan Kestenbaum Journal: Clin J Am Soc Nephrol Date: 2020-03-09 Impact factor: 8.237
Authors: Ke Wang; Leila R Zelnick; Andrew N Hoofnagle; Yan Chen; Ian H de Boer; Jonathan Himmelfarb; Bryan Kestenbaum Journal: Nephrol Dial Transplant Date: 2020-11-01 Impact factor: 5.992
Authors: Yan Chen; Leila R Zelnick; Ke Wang; Andrew N Hoofnagle; Jessica O Becker; Chi-Yuan Hsu; Harold I Feldman; Rupal C Mehta; James P Lash; Sushrut S Waikar; Tariq Shafi; Stephen L Seliger; Michael G Shlipak; Mahboob Rahman; Bryan R Kestenbaum Journal: J Am Soc Nephrol Date: 2020-03-23 Impact factor: 10.121
Authors: Alexander L Bullen; Simon B Ascher; Rebecca Scherzer; Pranav S Garimella; Ronit Katz; Stein I Hallan; Alfred K Cheung; Kalani L Raphael; Michelle M Estrella; Vasantha K Jotwani; Rakesh Malhotra; Jesse C Seegmiller; Michael G Shlipak; Joachim H Ix Journal: J Am Soc Nephrol Date: 2022-08-16 Impact factor: 14.978